NM_000152.5:c.351G>A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_Very_StrongBP7BS2_Supporting
The NM_000152.5(GAA):c.351G>A(p.Leu117Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000437 in 1,612,348 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000152.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000969 AC: 240AN: 247670Hom.: 5 AF XY: 0.00121 AC XY: 163AN XY: 134650
GnomAD4 exome AF: 0.000460 AC: 671AN: 1460012Hom.: 11 Cov.: 36 AF XY: 0.000632 AC XY: 459AN XY: 726300
GnomAD4 genome AF: 0.000223 AC: 34AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74496
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
GAA-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Glycogen storage disease, type II Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at